Haley, R.W., Kurt, T.L., and Hom, J. 1997b. Is there a Gulf War syndrome? Searching for syndromes by factor analysis of symptoms. JAMA 277(3):215–222.
IOM (Institute of Medicine). 1994. Committee on the DoD Persian Gulf Syndrome Comprehensive Clinical Evaluation Program: First Report. Washington, D.C.: IOM.
IOM. 1995. Committee on the DoD Persian Gulf Syndrome Comprehensive Clinical Evaluation Program: Second Report. Washington, D.C.: IOM.
IOM. 1996a. Evaluation of the U.S. Department of Defense Persian Gulf Comprehensive Clinical Evaluation Program. Washington, D.C.: National Academy Press.
IOM 1996b. Health Consequences of Service During the Persian Gulf War: Recommendations for Research and Information Systems. Washington, D.C.: National Academy Press.
Iowa Persian Gulf Study Group. 1997. Self-reported illness and health status among Gulf War veterans: A population-based study. JAMA 277(3):238–245.
Lotti, M. Moretto, A., Capodicasa, E., et al. 1993. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Toxicol Appl Pharmacol 122:165–171.
Marrs, T.C., Maynard, R.L., and Sidell, F.R. 1996 A History of Human Studies with Nerve Agents by the UK and USA in Chemical Warfare Agents: Toxicology and Treatment. New York: John Wiley & Sons.
Morita, H., Yanagisawa, N., Nakajima, T., et. al. 1995. Sarin poisoning in Matsumoto, Japan. Lancet 346:290–293.
MRICD (Medical Research Institute of Chemical Defense). 1995. Medical Management of Chemical Casualties, Second Edition. Aberdeen Proving Ground, MD: MRICD.
NAS (National Academy of Sciences). 1982. Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents. Volume 1: Anticholinesterases and Anticholinergics. Washington, D.C.: National Academy Press.
Presidential Advisory Committee on Gulf War Veterans' Illnesses. 1996. Final Report. Washington, D.C.: U.S. Government Printing Office.
White, R.F., Gerr, F., Cohen, R.F., et al. 1994. Criteria for progressive modification of neurobehavioral batteries. Neurotoxicol Teratol 16(5):511–524.
White, R.F., and Proctor, S.P. 1992. Research and clinical criteria for development of neurobehavioral test batteries. J Occupat Med 34:140–148.
Xintaras, C., and Burg, J.A.R. 1980 Screening and prevention of human neurotoxic outbreaks: Issues and problems. Experimental and Clinical Neurotoxicology edited by Spencer, P.S. and Schaumburg, H.H. Baltimore: Williams & Wilkins. 663–674.